Graves hyperthyroidism and pregnancy: A clinical update

Endocrine Practice

Volumn 16, Issue 1, 2010, Pages 118-129

  Patil Sisodia, Komal ^a   Mestman, Jorge H ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; ATENOLOL; CHORIONIC GONADOTROPIN; ESMOLOL; GLUCOCORTICOID; IODINE; IODINE 131; LUGOL; POTASSIUM IODIDE; PROPRANOLOL; PROPYLTHIOURACIL; RADIOACTIVE IODINE; THIAMAZOLE; THIOURACIL; THYROID HORMONE; THYROID STIMULATING IMMUNOGLOBULIN; THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE;

AGRANULOCYTOSIS; CHOANA ATRESIA; CONGESTIVE HEART FAILURE; CONTINUOUS INFUSION; DEVELOPMENTAL DISORDER; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; FACE DYSMORPHIA; FEMALE; FIRST TRIMESTER PREGNANCY; GRAVES DISEASE; HEARING LOSS; HEPATITIS; HUMAN; HYPEREMESIS GRAVIDARUM; HYPERTHYROIDISM; HYPOTHYROIDISM; INTRAUTERINE GROWTH RETARDATION; LIVER FAILURE; LOW BIRTH WEIGHT; LUPUS LIKE SYNDROME; MATERNAL CARE; MATERNAL HYPERTENSION; NEWBORN DISEASE; OBSTRUCTIVE JAUNDICE; PARENTERAL NUTRITION; PATIENT EDUCATION; PHYSICAL DISEASE BY BODY FUNCTION; PHYSIOLOGY; POLYARTHRITIS; POSTPARTUM THYROIDITIS; PREECLAMPSIA; PREGNANCY; PREGNANCY TEST; PREMATURE LABOR; PRURITUS; PUERPERIUM; RASH; RECOMMENDED DRUG DOSE; REVIEW; RISK REDUCTION; SKIN APLASIA; SMALL FOR DATE INFANT; SOLUTIO PLACENTAE; SUBTOTAL THYROIDECTOMY; THYROID CRISIS; THYROID DISEASE; THYROID FUNCTION; THYROTOXICOSIS;

FEMALE; GRAVES DISEASE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; THYROTOXICOSIS;

EID: 77649171334     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP09233.RA     Document Type: Review

References (58)

1. Burrow GN. Thyroid function and hyperfunction during gestation. Endocr Rev. 1993;14:194-202.
2. Glinoer D. Thyroid hyperfunction in pregnancy. Thyroid. 1998;8:859-864.
3. Mestman JH. Hyperthyroidism in pregnancy. Best Pract Res Clin Endocrinol Metab. 2004;18:267-288.
4. Gardiner-Hill H. Pregnancy complicating simple goiter and Graves' disease. Lancet. 1929;66:132-133.
5. Mussey RD, Haines SF, Ward E. Hyperthyroidism and pregnancy. Am J Obstet Gynecol. 1948;55:609-619.
6. Astwood EB. The use of antithyroid drugs during pregnancy. J Clin Endocrinol. 1951;10:1045-1056.
7. Piper J, Rosen J. Management of hyperthyroidism during pregnancy. Act Med Scand. 1954;150:215-222.
8. Herbst AL, Selenkow HA. Hyperthyroidism during pregnancy. N Engl J Med. 1965;273:627-633.
9. Werner SC. Two panel discussions on hyperthyroidism. J Clin Endocrinol Metab. 1967;27:1637-1654.
10. Mestman JH, Manning PR, Hodgman J. Hyperthyroidism and pregnancy. Arch Intern Med. 1974;134:434-439.
11. Laurberg P, Wallin G, Tallstedt L, Abraham-Nordling M, Lundell G, Tørring O. TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: A 5-year prospective randomized study. Eur J Endocrinol. 2008;158:69-75.
12. Tagami T, Hagiwara H, Kimura T, Usui T, Shimatsu A, Naruse M. The incidence of gestational hyperthyroidism and postpartum thyroiditis in treated patients with Graves' disease. Thyroid. 2007;17:767-772.
13. Gherman RB, Mestman JH, Satin AJ, Goodwin TM. Intractable hyperemesis gravidarum, transient hyperthyroidism and intrauterine growth restriction associated with hyperreactio luteinalis. A case report. J Reprod Med. 2005;48:553-556.
14. Rodien P, Brémont C, Sanson ML, et al. Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin. N Engl J Med. 1998;339:1823-1826.
15. Ginsberg J, Lewanczuk RZ, Honore LH. Hyperplacentosis: A novel cause of hyperthyroidism. Thyroid. 2001;11:393-396.
16. Yoshimura M, Hershman JM. Thyrotropic action of human chorionic gonadotropin. Thyroid. 1995;5:425-434.
17. Yeo CP, Khoo DH, Eng PH, Tan HK, Yo SL, Jacob E. Prevalence of gestational thyrotoxicosis in Asian women evaluated in the 8th to 14th weeks of pregnancy: Correlations with total and free beta human chorionic gonadotrophin. Clin Endocrinol (Oxf). 2001;55:391-398.
18. Goodwin TM, Hershman JM. Hyperthyroidism due to inappropriate production of human chorionic gonadotropin. Clin Obstet Gynecol. 1997;40:32-44.
19. Smallridge RC, Glinoer D, Hollowell JG, Brent G. Thyroid function inside and outside of pregnancy: What do we know and what don't we know? Thyroid. 2005;15:54-59.
20. Lee RH, Spencer CA, Mestman JH, et al. Free T4 immunoassays are flawed during pregnancy. Am J Obstet Gynecol. 2009;200:260.
21. Sapin R, D'Herbomez M, Schlienger JL. Free thyroxine measured with equilibrium dialysis and nine immunoassays decreases in late pregnancy. Clin Lab. 2004;50:581-584.
22. Soldin OP, Tractenberg RE, Hollowell JG, Jonklaas J, Janicic N, Soldin SJ. Trimester-specific changes in maternal thyroid hormone, thyrotropin, and thyroglobulin concentrations during gestation: Trends and associations across trimesters in iodine sufficiency. Thyroid. 2004;14:1084-1090.
23. Kahric-Janicic N, Soldin SJ, Soldin OP, West T, Gu J, Jonklaas J. Tandem mass spectrometry improves the accuracy of free thyroxine measurements during pregnancy. Thyroid. 2007;17:303-311.
24. Peleg D, Cada S, Peleg A, Ben-Ami M. The relationship between maternal serum thyroid-stimulating immunoglobulin and fetal and neonatal thyrotoxicosis. Obstet Gynecol. 2002;99:1040-1043.
25. Zakarija M, McKenzie JM. Pregnancy-associated changes in the thyroid-stimulating antibody of Graves' disease and the relationship to neonatal hyperthyroidism. J Clin Endocrinol Metab. 1983;57:1036-1040.
26. Amino N, Izumi Y, Hidaka Y, et al. No increase of blocking type anti-thyrotropin receptor antibodies during pregnancy in patients with Graves' disease. J Clin Endocrinol Metab. 2003;88:5871-5874.
27. Momotani N, Noh J, Oyanagi H, Ishikawa N, Ito K. Antithyroid drug therapy for Graves' disease during pregnancy. Optimal regimen for fetal thyroid status. N Engl J Med. 1986;315:24-28.
28. Sherif IH, Oyan WT, Bosairi S, Carrascal SM. Treatment of hyperthyroidism in pregnancy. Acta Obstet Gynecol Scand. 1991;70:461-463.
29. Bruner JP, Landon MB, Gabbe SG. Diabetes mellitus and Graves' disease in pregnancy complicated by maternal allergies to antithyroid medication. Obstet Gynecol. 1988;72:443-445.
30. Momotani N, Hisaoka T, Noh J, Ishikawa N, Ito K. Effects of iodine on thyroid status of fetus versus mother in treatment of Graves' disease complicated by pregnancy. J Clin Endocrinol Metab. 1992;75:738-744.
31. Stoffer SS, Hamburger JI. Inadvertent 131I therapy for hyperthyroidism in the first trimester of pregnancy. J Nucl Med. 1976;17:146-149.
32. Cooper DS. Antithyroid drugs in the management of patients with Graves' disease: An evidence-based approach to therapeutic controversies. J Clin Endocrinol Metab. 2003;88:3474-3481.
33. Williams KV, Nayak S, Becker D, Reyes J, Burmeister LA. Fifty years of experience with propylthiouracil-associated hepatotoxicity: What have we learned? J Clin Endocrinol Metab. 1997;82:1727-1733.
34. Russo MW, Galanko JA, Shrestha R, Fried MW, Watkins P. Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transpl. 2004;10:1018-1023.
35. Clementi M, Di Gianantonio E, Pelo E, Mammi I, Basile RT, Tenconi R. Methimazole embryopathy: Delineation of the phenotype. Am J Med Genet. 1999;83:43-66.
36. Di Gianantonio E, Schaefer C, Mastroiacovo PP, et al. Adverse effects of prenatal methimazole exposure. Teratology. 2001;64:262-266.
37. Wolf D, Foulds N, Daya H. Antenatal carbimazole and choanal atresia: A new embryopathy. Arch Otolaryngol Head Neck Surg. 2006;132:1009-1011.
38. Cheron RG, Kaplan MM, Larsen PR, Selenkow HA, Crigler JF Jr. Neonatal thyroid function after propylthiouracil therapy for maternal Graves' disease. N Engl J Med. 1981;304:525-528.
39. Cooper DS, Rivkees SA. Putting propylthiouracil in perspective. J Clin Endocrinol Metab. 2009;94:1881-1882.
40. Chattaway JM, Klepser TB. Propylthiouracil versus methimazole in treatment of Graves' disease during pregnancy. Ann Pharmacother. 2007;41:1018-1022.
41. Wing DA, Millar LK, Koonings PP, Montoro MN, Mestman JH. A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy. Am J Obstet Gynecol. 1994;170:90-95.
42. Momotani N, Noh JY, Ishikawa N, Ito K. Effects of propylthiouracil and methimazole on fetal thyroid status in motehrs with Graves' hyperthyroidism. J Clin Endocrinol Metabol. 1997;82:3633-3636.
43. Barbero P, Valdez R, Rodríguez H, et al. Choanal atresia associated with maternal hyperthyroidism treated with methimazole: A case-control study. Am J Med Genet A. 2008;146A:2390-2395.
44. Millar LK, Wing DA, Leung AS, Koonings PP, Montoro MN, Mestman JH. Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstet Gynecol. 1994;84:946-949.
45. Easterling TR, Schmucker BC, Carlson KL, Millard SP, Benedetti TJ. Maternal hemodynamics in pregnancies complicated by hyperthyroidism. Obstet Gynecol. 1991;78:348-352.
46. Clark SL, Phelan JP, Montoro M, Mestman J. Transient ventricular dysfunction associated with cesarean section in a patient with hyperthyroidism. Am J Obstet Gynecol. 1985;151:384-386.
47. Davis LE, Lucas MJ, Hankins GD, Roark ML, Cunningham FG. Thyrotoxicosis complicating pregnancy. Am J Obstet Gynecol. 1989;160:63-70.
48. Luton D, LeGac I, Vuillard E, et al. Management of Graves' disease during pregnancy: The key role of fetal thyroid gland monitoring. J Clin Endocrinol Metab. 2005;90:6093-6098.
49. Polak M, Le Gac I, Vuillard E, et al. Fetal and neonatal thyroid function in relation to maternal Graves' disease. Best Prac Res Clin Endocrinol Metab. 2004;18:289-302.
50. Grüner C, Kollert A, Wildt L, Dörr HG, Beinder E, Lang N. Intrauterine treatment of fetal goitrous hypothyroidism controlled by determination of thyroid-stimulating hormone in fetal serum. A case report and review of the literature. Fetal Diagn Ther. 2001;16:47-51.
51. Nachum Z, Rakover Y, Weiner E, Shalev E. Graves' disease in pregnancy: Prospective evaluation of a selective invasive treatment protocol. Am J Obstet Gynecol. 2003;189:159-165.
52. Matsuura N, Konishi J, Fujieda K, et al. TSH-receptor antibodies in mothers with Graves' disease and outcome in their offspring. Lancet. 1988;1:14-17.
53. Cove DH, Johnston P. Fetal hyperthyroidism: Experience of treatment is four siblings. Lancet. 1985;1:430-432.
54. Dussault JH. Neonatal screening for congenital hypothyroidism. Clin Lab Med. 1993;13:645-652.
55. Kempers MJ, van Tijn DA, van Trotsenburg AS, de Vijlder JJ, Wiedijk BM, Vulsma T. Central congenital hypothyroidism due to gestational hyperthyroidism: Detection where prevention failed. J Clin Endocrinol Metab. 2003;88:5851-5857.
56. Rotondi M, Cappelli C, Pirali B, et al. The effect of pregnancy on subsequent relapse from Graves' disease after a successful course of antithyroid drug therapy. J Clin Endocrinol Metab. 2008;93:3985-3988.
57. Momotani N, Yamashita R, Makino F, Noh JY, Ishikawa N, Ito K. Thyroid function in wholly breast-feeding infants whose mothers take high doses of propylthiouracil. Clin Endocrinol (Oxf). 2000;53:177-181.
58. Azizi F, Bahrainian M, Khamseh ME, Khoshniat M. Intellectual development and thyroid function in children who were breast-fed by thyrotoxic mothers taking methimazole. J Pediatr Endocrinol Metab. 2003;16:1239-1243.